C8orf74
gene geneOn this page
Summary
C8orf74 (chromosome 8 open reading frame 74, HGNC:32296) is a protein-coding gene on chromosome 8p23.1, encoding Uncharacterized protein C8orf74 (Q6P047).
At a glance
- GWAS associations: 15
- Clinical variants (ClinVar): 27 total — 9 pathogenic
- MANE Select transcript:
NM_001040032
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32296 |
| Approved symbol | C8orf74 |
| Name | chromosome 8 open reading frame 74 |
| Location | 8p23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000171060 |
| Ensembl biotype | protein_coding |
| Entrez | 203076 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 3 protein_coding_CDS_not_defined, 2 protein_coding, 2 nonsense_mediated_decay
ENST00000304519, ENST00000517414, ENST00000519925, ENST00000521818, ENST00000523289, ENST00000523723, ENST00000524025
RefSeq mRNA: 1 — MANE Select: NM_001040032
NM_001040032
CCDS: CCDS47800
Canonical transcript exons
ENST00000304519 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001166869 | 10700235 | 10700590 |
| ENSE00001304284 | 10672628 | 10672713 |
| ENSE00003540714 | 10697599 | 10698005 |
| ENSE00003639279 | 10674646 | 10674838 |
Expression profiles
Bgee: expression breadth broad, 59 present calls, max score 81.31.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0463 / max 36.9890, expressed in 4 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 87370 | 0.0295 | 4 |
| 87369 | 0.0135 | 3 |
| 87371 | 0.0033 | 2 |
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 81.31 | gold quality |
| right testis | UBERON:0004534 | 81.10 | gold quality |
| testis | UBERON:0000473 | 80.75 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.27 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.49 | gold quality |
| adenohypophysis | UBERON:0002196 | 65.27 | gold quality |
| pituitary gland | UBERON:0000007 | 63.55 | gold quality |
| skin of leg | UBERON:0001511 | 61.65 | gold quality |
| zone of skin | UBERON:0000014 | 60.79 | gold quality |
| skin of abdomen | UBERON:0001416 | 59.35 | gold quality |
| sural nerve | UBERON:0015488 | 58.39 | silver quality |
| esophagus mucosa | UBERON:0002469 | 56.02 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 55.43 | gold quality |
| vagina | UBERON:0000996 | 50.64 | gold quality |
| endometrium | UBERON:0001295 | 50.58 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 48.82 | gold quality |
| tonsil | UBERON:0002372 | 43.98 | gold quality |
| left adrenal gland | UBERON:0001234 | 43.67 | gold quality |
| right adrenal gland | UBERON:0001233 | 43.41 | gold quality |
| adrenal gland | UBERON:0002369 | 42.89 | gold quality |
| bone marrow cell | CL:0002092 | 42.88 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 42.28 | gold quality |
| esophagus | UBERON:0001043 | 42.27 | gold quality |
| gall bladder | UBERON:0002110 | 41.58 | gold quality |
| urinary bladder | UBERON:0001255 | 41.47 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.39 | gold quality |
| ectocervix | UBERON:0012249 | 40.60 | gold quality |
| monocyte | CL:0000576 | 40.46 | silver quality |
| uterine cervix | UBERON:0000002 | 40.46 | gold quality |
| leukocyte | CL:0000738 | 39.79 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.10 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
5 targeting C8orf74, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-6895-3P | 98.79 | 65.69 | 996 |
| HSA-MIR-34B-3P | 98.70 | 67.40 | 1171 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | 4930578I06Rik | ENSMUSG00000021961 |
| rattus_norvegicus | C15h8orf74 | ENSRNOG00000012402 |
Paralogs (1): CFAP119 (ENSG00000196118)
Protein
Protein identifiers
Uncharacterized protein C8orf74 — Q6P047 (reviewed: Q6P047)
All UniProt accessions (3): E5RJ53, Q6P047, H0YBH0
UniProt curated annotations — full annotation on UniProt →
RefSeq proteins (1): NP_001035121* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032727 | CLAMP | Family |
Pfam: PF14769
UniProt features (5 total): sequence variant 2, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P047-F1 | 85.71 | 0.65 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 21 (showing top):
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN, HES2_TARGET_GENES, ZNF184_TARGET_GENES, GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP, BRCA2_TARGET_GENES, ZSCAN4_TARGET_GENES, NOTCH3_TARGET_GENES, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP, GSE27786_BCELL_VS_CD4_TCELL_DN, WP_8P231_COPY_NUMBER_VARIATION_SYNDROME, PULVER_FOREY_CELLCYCLE_PEAKING_S2, GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN, GSE3039_CD4_TCELL_VS_B1_BCELL_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
168 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C8orf74 | NKX2-4 | Q9H2Z4 | 543 |
| C8orf74 | SATL1 | Q86VE3 | 479 |
| C8orf74 | KIZ | Q2M2Z5 | 472 |
| C8orf74 | XKR6 | Q5GH73 | 417 |
| C8orf74 | C1orf141 | Q5JVX7 | 410 |
| C8orf74 | KCNN2 | Q9H2S1 | 398 |
| C8orf74 | PRSS55 | Q6UWB4 | 394 |
| C8orf74 | SOX7 | Q9BT81 | 348 |
| C8orf74 | MSRA | Q9UJ68 | 348 |
| C8orf74 | MFHAS1 | Q9Y4C4 | 322 |
| C8orf74 | PPP1R3B | Q86XI6 | 322 |
| C8orf74 | A0A0G2JN59 | A0A0G2JN59 | 305 |
| C8orf74 | XRN2 | Q9H0D6 | 305 |
| C8orf74 | ANO4 | Q32M45 | 295 |
| C8orf74 | MTMR9 | Q96QG7 | 291 |
IntAct
16 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C8orf74 | ZNF655 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C8orf74 | FGFR2 | psi-mi:“MI:0914”(association) | 0.530 |
| C8orf74 | SUV39H1 | psi-mi:“MI:0915”(physical association) | 0.510 |
| KDM1A | C8orf74 | psi-mi:“MI:0915”(physical association) | 0.510 |
| C8orf74 | PRMT6 | psi-mi:“MI:0915”(physical association) | 0.510 |
| C8orf74 | KDM1A | psi-mi:“MI:0915”(physical association) | 0.510 |
| PRMT6 | C8orf74 | psi-mi:“MI:0915”(physical association) | 0.510 |
| SUV39H1 | C8orf74 | psi-mi:“MI:0915”(physical association) | 0.510 |
| C8orf74 | SUV39H2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TRIM63 | C8orf74 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TRIM55 | C8orf74 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TRIM54 | C8orf74 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C8orf74 | ZNF655 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (19): FGFR2 (Affinity Capture-MS), MORN2 (Affinity Capture-MS), TMEM259 (Affinity Capture-MS), FGFR2 (Affinity Capture-MS), MORN2 (Affinity Capture-MS), C8orf74 (Positive Genetic), ZNF655 (Two-hybrid), C8orf74 (Two-hybrid), C8orf74 (Two-hybrid), C8orf74 (Two-hybrid), FGFR2 (Affinity Capture-MS), MORN2 (Affinity Capture-MS), KDM1A (Affinity Capture-Luminescence), PRMT6 (Affinity Capture-Luminescence), SUV39H1 (Affinity Capture-Luminescence)
ESM2 similar proteins: A0A1L8GUX5, A0A571BF63, A0A8M9QN10, A1L1K1, A2ARM1, A2AVJ5, A7YDW0, O08576, O60268, P0C6P5, P97433, Q08E29, Q0V9V7, Q0VDN7, Q17QK1, Q2NKQ1, Q2NL11, Q3B7K9, Q3SYZ9, Q4R7B9, Q561Q8, Q59EK9, Q5E9L4, Q5E9R0, Q5EB20, Q5NVC2, Q5PQS0, Q5R565, Q5U3W3, Q5XHG1, Q61194, Q6AYK4, Q6MZQ0, Q6NXJ0, Q6P047, Q6P7D5, Q6ZUJ8, Q80ZQ3, Q8BPQ7, Q8N1W1
Diamond homologs: Q2NL11, Q6P047, Q80ZQ3, A1A4V9, B0BMZ6, Q6NZQ0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
27 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 9 |
| Likely pathogenic | 0 |
| Uncertain significance | 11 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (9)
| Variant ID | HGVS | Classification |
|---|---|---|
| 145585 | GRCh38/hg38 8p23.1(chr8:8273108-12546553)x3 | Pathogenic |
| 152872 | GRCh38/hg38 8p23.1(chr8:8253505-11422633)x1 | Pathogenic |
| 152960 | GRCh38/hg38 8p23.1(chr8:9456230-11013618)x1 | Pathogenic |
| 153058 | GRCh38/hg38 8p23.1(chr8:8764178-11063564)x3 | Pathogenic |
| 1703667 | GRCh37/hg19 8p23.1(chr8:8093168-11898980) | Pathogenic |
| 2685282 | GRCh37/hg19 8p23.3-23.1(chr8:158049-11898696)x1 | Pathogenic |
| 4526777 | NC_000008.11:g.10540410_10703730del | Pathogenic |
| 688534 | GRCh37/hg19 8p23.1(chr8:8093169-11898980)x1 | Pathogenic |
| 815086 | GRCh37/hg19 8p23.1(chr8:8093169-11936001)x1 | Pathogenic |
SpliceAI
711 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:10674800:TGGTC:T | donor_gain | 1.0000 |
| 8:10698003:CAGGT:C | donor_loss | 1.0000 |
| 8:10698004:AGGTG:A | donor_loss | 1.0000 |
| 8:10698005:GGTGA:G | donor_loss | 1.0000 |
| 8:10698006:GTG:G | donor_loss | 1.0000 |
| 8:10700231:CCAG:C | acceptor_loss | 1.0000 |
| 8:10700234:GGA:G | acceptor_gain | 1.0000 |
| 8:10672720:G:GT | donor_gain | 0.9900 |
| 8:10674642:GCAGA:G | acceptor_loss | 0.9900 |
| 8:10674644:A:AG | acceptor_gain | 0.9900 |
| 8:10674644:A:AT | acceptor_loss | 0.9900 |
| 8:10674645:G:GG | acceptor_gain | 0.9900 |
| 8:10674645:GA:G | acceptor_gain | 0.9900 |
| 8:10674801:G:GA | donor_gain | 0.9900 |
| 8:10698001:GACAG:G | donor_gain | 0.9900 |
| 8:10698006:G:GG | donor_gain | 0.9900 |
| 8:10698007:T:A | donor_loss | 0.9900 |
| 8:10700233:A:AG | acceptor_gain | 0.9900 |
| 8:10700233:AG:A | acceptor_gain | 0.9900 |
| 8:10700234:G:GC | acceptor_gain | 0.9900 |
| 8:10700234:GG:G | acceptor_gain | 0.9900 |
| 8:10700234:GGAGT:G | acceptor_gain | 0.9900 |
| 8:10674641:TGCAG:T | acceptor_gain | 0.9800 |
| 8:10674643:CAG:C | acceptor_gain | 0.9800 |
| 8:10674644:AGA:A | acceptor_gain | 0.9800 |
| 8:10674645:G:C | acceptor_gain | 0.9800 |
| 8:10674645:GAGA:G | acceptor_gain | 0.9800 |
| 8:10674645:GAGAC:G | acceptor_gain | 0.9800 |
| 8:10674823:C:G | donor_gain | 0.9800 |
| 8:10674834:CAAAG:C | donor_loss | 0.9800 |
AlphaMissense
1912 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:10674748:A:C | S51R | 0.984 |
| 8:10674750:C:A | S51R | 0.984 |
| 8:10674750:C:G | S51R | 0.984 |
| 8:10674761:C:A | A55E | 0.978 |
| 8:10674757:T:C | F54L | 0.972 |
| 8:10674759:T:A | F54L | 0.972 |
| 8:10674759:T:G | F54L | 0.972 |
| 8:10674776:T:C | F60S | 0.960 |
| 8:10674821:T:C | L75P | 0.960 |
| 8:10674781:T:A | W62R | 0.951 |
| 8:10674781:T:C | W62R | 0.951 |
| 8:10697616:G:C | A87P | 0.951 |
| 8:10674775:T:C | F60L | 0.940 |
| 8:10674777:C:A | F60L | 0.940 |
| 8:10674777:C:G | F60L | 0.940 |
| 8:10697823:G:C | G156R | 0.938 |
| 8:10700335:T:C | L250P | 0.936 |
| 8:10674668:T:C | L24P | 0.935 |
| 8:10674809:T:C | F71S | 0.931 |
| 8:10700341:T:C | L252P | 0.928 |
| 8:10674760:G:C | A55P | 0.916 |
| 8:10674783:G:C | W62C | 0.914 |
| 8:10674783:G:T | W62C | 0.914 |
| 8:10697641:T:C | L95P | 0.907 |
| 8:10674655:G:C | G20R | 0.904 |
| 8:10700319:T:C | F245L | 0.903 |
| 8:10700321:C:A | F245L | 0.903 |
| 8:10700321:C:G | F245L | 0.903 |
| 8:10672702:T:C | F13L | 0.897 |
| 8:10672704:C:A | F13L | 0.897 |
dbSNP variants (sampled 300 via entrez): RS1000113972 (8:10688627 G>C), RS1000117924 (8:10677608 C>A,T), RS1000118517 (8:10683032 G>A,C,T), RS1000132404 (8:10673898 T>C), RS1000192106 (8:10677371 C>A,G), RS1000197943 (8:10672006 C>A), RS1000309186 (8:10698499 G>A,C), RS1000331365 (8:10681087 G>T), RS1000557868 (8:10671209 G>C,T), RS1000611254 (8:10691157 AAGTT>A), RS1000705456 (8:10693308 C>A,T), RS1000763843 (8:10694955 G>T), RS1000782424 (8:10694225 T>A,C,G), RS1000839927 (8:10683803 G>A,C), RS1000932802 (8:10684001 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
15 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002973_3 | Suicide | 4.000000e-06 |
| GCST007556_1 | Autism spectrum disorder | 1.000000e-08 |
| GCST010132_11 | Processed meat consumption | 4.000000e-10 |
| GCST010132_14 | Processed meat consumption | 2.000000e-15 |
| GCST010132_15 | Processed meat consumption | 1.000000e-09 |
| GCST010137_2 | Cooked vegetable consumption | 2.000000e-10 |
| GCST010142_4 | Fish- and plant-related diet | 2.000000e-12 |
| GCST010142_6 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010142_63 | Fish- and plant-related diet | 2.000000e-12 |
| GCST010142_67 | Fish- and plant-related diet | 1.000000e-10 |
| GCST010142_70 | Fish- and plant-related diet | 8.000000e-10 |
| GCST010142_89 | Fish- and plant-related diet | 4.000000e-16 |
| GCST010142_90 | Fish- and plant-related diet | 7.000000e-15 |
| GCST010703_306 | Brain morphology (MOSTest) | 5.000000e-26 |
| GCST90011898_107 | Alanine aminotransferase levels | 2.000000e-19 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007624 | suicide |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 2 |
| Benzo(a)pyrene | affects methylation | 2 |
| sodium arsenite | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| p-Chloromercuribenzoic Acid | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.